The Role of Plasminogen Activation in Smooth Muscle Cell Migration after Arterial Injury

Annals of the New York Academy of Sciences

Volumn 667, Issue 1, 1992, Pages 141-150

  JACKSON, CHRISTOPHER L ^a   REIDY, MICHAEL A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; LISINOPRIL; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTERY MUSCLE; BALLOON CATHETER; CELL MIGRATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FIBRINOLYSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER;

ANIMAL; ANTIHYPERTENSIVE AGENTS; BALLOON DILATATION; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL MOVEMENT; DIPEPTIDES; IN VITRO; KINETICS; LISINOPRIL; MALE; MUSCLE, SMOOTH, VASCULAR; PLASMIN; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA;

EID: 0027054917     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1992.tb51606.x     Document Type: Article

References (23)

1. Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium
2. Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator
3. On the production of plasma fibrinolytic activity within veins
4. Demonstration of plasminogen activator activity in the intima and media of the normal human aorta and other large arteries: Immunological identification of the plasminogen activator(s)
5. Distribution of tissue‐type plasminogen activator (activity and antigen) in rat tissues
6. Smooth muscle cells express urokinase during mitogenesis and tissue‐type plasminogen activator during migration in injured rat carotid artery
7. A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat
8. Inhibitors of angiotensin‐converting enzyme prevent myointimal proliferation after vascular injury
9. Effect of ramipril, an inhibitor of angiotensin converting enzyme, on the response of rat thoracic aorta to injury with a balloon catheter
10. Influence of the angiotensin system on endothelial and smooth muscle cell migration
11. Quantitative assessment of subcutaneous fibrinolysis in the rat
12. Amiloride selectively inhibits the urokinase‐type plasminogen activator
13. Significance of quiescent smooth muscle cell migration in the injured rat carotid artery
14. Anchorage independent growth and plasminogen activator production by bovine endothelial cells
15. Cultured bovine endothelial cells produce both urokinase and tissue‐type plasminogen activators
16. Inhibition of endothelial secretion of tissue‐type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP
17. Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells
18. Plasminogen activation and regulation of pericellular proteolysis
19. Clinical application of inhibitors of fibrinolysis
20. Basis of antifibrinolytic therapy
21. Fate of angiotensin I in the circulation
22. Conversion of angiotensin I to angiotensin II by cell‐free extracts of dog lung
23. Accentuated vascular and endocrine response to SQ 20881 in hypertension. New Engl